109 related articles for article (PubMed ID: 19508679)
1. Dose-dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0.1, 0.3 and 0.9 mg of rhTSH.
Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
Clin Endocrinol (Oxf); 2010 Mar; 72(3):411-6. PubMed ID: 19508679
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
6. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human TSH on the uptake of radioactive iodine ((123)I) by the thyroid gland in healthy beagles.
Campos M; Peremans K; Duchateau L; Dobbeleir A; Vandermeulen E; van Hoek I; Paes G; Daminet S
Domest Anim Endocrinol; 2010 Nov; 39(4):215-21. PubMed ID: 20688462
[TBL] [Abstract][Full Text] [Related]
8. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects.
Torres MS; Ramirez L; Simkin PH; Braverman LE; Emerson CH
J Clin Endocrinol Metab; 2001 Apr; 86(4):1660-4. PubMed ID: 11297600
[TBL] [Abstract][Full Text] [Related]
9. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.
Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3424-8. PubMed ID: 17566091
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.
Pitoia F; Tamer EE; Schere DB; Passerieu M; Bruno OD; Niepomniszcze H
Medicina (B Aires); 2006; 66(2):125-30. PubMed ID: 16715760
[TBL] [Abstract][Full Text] [Related]
11. [Response of thyroglobulin, anti-thyroglobulin antibodies, TSH, FT4 and total T3 after rhTSH stimulation in differentiated thyroid carcinoma].
Moreno Ortega E; Vallejo Casas JA; Mena Bares LM; del Real Núñez R; Maza Muret FR; Hidalgo Ramos FJ; Latre Romero JM
Rev Esp Med Nucl; 2008; 27(4):253-8. PubMed ID: 18682151
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
[TBL] [Abstract][Full Text] [Related]
13. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
[TBL] [Abstract][Full Text] [Related]
14. Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.
Nielsen VE; Bonnema SJ; Hegedüs L
J Clin Endocrinol Metab; 2006 Apr; 91(4):1317-22. PubMed ID: 16434453
[TBL] [Abstract][Full Text] [Related]
15. 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.
Pena S; Arum S; Cross M; Magnani B; Pearce EN; Oates ME; Braverman LE
J Clin Endocrinol Metab; 2006 Feb; 91(2):506-10. PubMed ID: 16317054
[TBL] [Abstract][Full Text] [Related]
16. Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial.
Nielsen VE; Bonnema SJ; Hegedüs L
J Clin Endocrinol Metab; 2004 May; 89(5):2242-7. PubMed ID: 15126548
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects.
Ramirez L; Braverman LE; White B; Emerson CH
J Clin Endocrinol Metab; 1997 Sep; 82(9):2836-9. PubMed ID: 9284706
[TBL] [Abstract][Full Text] [Related]
18. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
[TBL] [Abstract][Full Text] [Related]
20. Enhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnant.
Desideri G; Bocale R; Milardi D; Ghiadoni L; Grassi D; Necozione S; Taddei S; di Orio F; Pontecorvi A; Ferri C
Clin Endocrinol (Oxf); 2009 Sep; 71(3):429-33. PubMed ID: 19067724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
